C-reactive-protein (CRP) is a cyclic pentameric protein. The CRP concentration in the blood of normal people is very low, but under stress conditions such as infection, trauma, surgery, tissue necrosis, and acute inflammation, the CRP concentration rises sharply; in the absence of inflammation, hypersensitivity CRP is an atherosclerotic thrombus The formed mediators and markers can be used to monitor potential cardiovascular risks from time to time and assist in the diagnosis of cardiovascular diseases.
Detection range | sample size | Sample type | Test time |
0.5~200mg/L | 5μl | Whole blood / serum / plasma | 3min |
Conventional C-reactive protein: monitoring of postoperative infections and complications; monitoring of inflammation treatment, monitoring of antibiotic use, etc.; differential diagnosis of bacterial/viral infections.
Test results | Clinical application recommendations |
---|---|
>25 | Bacterial infections |
10~25 | Prompt for viral infection. CRP should drop below this level during antibiotic treatment. If the course of the disease is short and bacterial infection cannot be ruled out, it should be reviewed in a few hours. |
<10 | The course of the disease is greater than 6-12 hours, which can basically rule out bacterial infection or the bacteria have been cleared |
>2 | Prompt neonatal infection |
---|---|
Concentration drop | The treatment is effective, and the condition improves (D4 ↓≥40%) when it drops to normal, stop antibiotic treatment |
Test results | Clinical application recommendations |
---|---|
>10 | Prompt bacterial infection, virus infection can be ruled out |
0 50~100 | Often bacterial infections, viral infections are not common |
25~50 | Prompt bacterial or viral infection |
10~25 | Prompt for viral infection. CRP should drop below this level during antibiotic treatment. If the course of the disease is short and bacterial infection cannot be ruled out, it should be reviewed in a few hours. |
3~10 | Cardiovascular disease: high risk, it is recommended to give anti-inflammatory and antithrombotic treatment at the same time |
1~3 | Cardiovascular disease: moderate risk, anti-inflammatory treatment is recommended. Check again after two weeks and take the average value as the basis of observation |
<1 | Cardiovascular disease: low risk |
Treatment goals | hsCRP <1mg/L |
Department of respiration, pediatrics, Gastroenterology, Urology, gynecology, Stomatology, oncology Cardiology, etc
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.